Valuation: Nanologica AB

Market Cap 106M 10.57M 9.31M 8.82M 7.96M 15.01M 1.01B 15.2M 40.61M 518M 39.7M 38.83M 1.66B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 106M 10.57M 9.31M 8.82M 7.96M 15.01M 1.01B 15.2M 40.61M 518M 39.7M 38.83M 1.66B EV / Sales 2026 *
0.95x
EV / Sales 2027 * 0.59x
Free-Float
32.62%
Yield 2026 *
-
Yield 2027 * -
1 day-4.67%
Current month-18.83%
1 month-18.83%
3 months-36.78%
6 months-18.18%
Current year-60.77%
1 week 0.3
Extreme 0.3
0.34
1 month 0.29
Extreme 0.286
0.49
Current year 0.29
Extreme 0.286
2.25
1 year 0.29
Extreme 0.286
2.25
3 years 0.29
Extreme 0.286
12.7
5 years 0.29
Extreme 0.286
17.45
10 years 0.29
Extreme 0.286
20
Manager TitleAgeSince
Chief Executive Officer 51 2010-12-31
Investor Relations Contact - -
Corporate Officer/Principal 57 2023-12-31
Director TitleAgeSince
Chairman 68 2013-12-31
Director/Board Member 63 2013-12-31
Director/Board Member 57 2018-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
12/21/21 Buy 115,000 0.4083%
6/9/21 Buy

Director

13,000 0.0468%
6/8/21 Buy

Chief Executive Officer

82,566 0.2971%
Change 5-day change 1-year change 3-year change Capi.($)
-4.67%0.00%-73.39%-96.90% 10.54M
-0.39%+0.06%+1.10%+65.90% 77.89B
-0.87%-0.26%+5.51%+15.99% 38.03B
-0.73%-0.54%+3.90%-20.00% 35.61B
-1.08%-1.67%+6.29%+8.05% 32.23B
+0.17%-4.09%+7.81%+51.66% 29.58B
+0.87%+0.72%-7.77%+16.01% 25.17B
-0.67%-1.32%+45.69%+33.36% 23.11B
-1.65%-6.02%+51.05%+15.43% 18.87B
+0.15%-0.43%-44.24%-40.76% 17.57B
Average -0.79%-1.25%-0.41%+4.87% 29.81B
Weighted average by Cap. -0.36%-1.45%+6.42%+25.38%

Financials

2026 *2027 *
Net sales 112M 11.17M 9.84M 9.32M 8.41M 15.86M 1.07B 16.06M 42.91M 548M 41.94M 41.03M 1.76B 179M 17.93M 15.79M 14.96M 13.51M 25.46M 1.72B 25.79M 68.88M 879M 67.33M 65.86M 2.82B
Net income - -
Net Debt - -
Logo Nanologica AB
Nanologica AB (publ) is a Sweden-based materials development company. The Company specializes in developing nanoporous materials from nanoporous silica (silicon dioxide) for a variety of applications, ranging from purification to pharmaceutical excipients. The Company's core competency has been developed and expanded in two areas of application, in particular: Drug Delivery and Chromatography, a technology used for the separation and purification of products on the market and in development. The Company's Drug Delivery sector operates within a niche domain of nanocarriers. Nanologica AB (publ)’s drug delivery technology is aimed on absorption of the medicine by the body for drugs that are poorly soluble in water.
Employees
72
Date Price Change Volume
26-09-30 SEK 0.3060 -4.67% 471,890
26-09-29 SEK 0.3210 +0.94% 377,192
26-09-28 SEK 0.3180 +2.58% 393,392
26-09-25 SEK 0.3100 -0.64% 334,071
26-09-24 SEK 0.3120 +1.96% 267,212

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NICA Stock